Table 2 Univariate and multivariate Cox regression analysis of factors associated with OS in LUAD.
Clinicopathological variables | Cox univariate analysis | Coxmultivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95%CI | P | HR | 95%CI | P | |
Gender (Female VS. Male) | 2.386 | 1.124-5. 065 | 0.024 | Â | Â | Â |
Age (≥ 60 years VS. < 60 years) | 0.678 | 0.34–1.3 49 | 0.268 |  |  |  |
Smoking (YES VS. NO) | 0.415 | 0.208-0. 827 | 0.012 | Â | Â | Â |
T staging (T3 + T4 VS. T1 + T2) | 0.424 | 0.219-0. 821 | 0.011 | 0.394 | 0.19–0.8 14 | 0.012 |
N staging (N0 + N1 VS. N2 + N3) | 0.482 | 0.25–0.9 26 | 0.029 | 0.356 | 0.13–0.9 78 | 0.045 |
M staging (M1 VS. M0) | 0.595 | 0.182-1. 941 | 0.389 | Â | Â | Â |
Clinical staging (I + II VS. III + IV) | 0.447 | 0.227-0. 884 | 0.021 | Â | Â | Â |
Lymph node metastasis (Yes VS. No) | 1.41 | 0.735-2. 708 | 0.301 | Â | Â | Â |
Recurrence (YES VS. NO) | 2.348 | 1.224-4. 504 | 0.01 | 2.323 | 1.182-4. 565 | 0.014 |
EGFR mutation (YES VS. NO) | 0.72 | 0.336-1. 542 | 0.398 | Â | Â | Â |
KRAS mutation (YES VS. NO) | 1.22 | 0.604-2. 463 | 0.58 | Â | Â | Â |
uH2B (Low expression VS. High expression) | 0.714 | 0.252-2. 028 | 0.527 | 0.787 | 0.261-2. 368 | 0.669 |